WarfarinAnticoagulantsVitamin K Epoxide ReductasesProthrombin TimeHemorrhageThromboembolismAtrial FibrillationMixed Function Oxygenasesbeta-AlanineVitamin KAryl Hydrocarbon HydroxylasesPharmacogeneticsRodenticidesDrug InteractionsAdministration, OralStrokeDrug MonitoringAspirinVitamin K 1Treatment OutcomeDrug Dosage CalculationsBenzimidazoles4-HydroxycoumarinsBlood CoagulationIntracranial HemorrhagesDrug Administration ScheduleEmbolismTime FactorsHerb-Drug InteractionsPlatelet Aggregation InhibitorsVenous ThrombosisAcenocoumarolDouble-Blind MethodThrombosisCarbon-Carbon LigasesRodent ControlThrombophlebitisVitamin K DeficiencyPyridonesDose-Response Relationship, DrugDrug Therapy, CombinationRadiation DosageLethal Dose 50PhenylbutazoneHeparin, Low-Molecular-WeightRetrospective StudiesVenous ThromboembolismAntithrombins